Skip to main content
logo
Bacil Pharma Limited (BOM:524516)
India flag India · Delayed Price · Currency is INR
20.44
-0.65 (-3.08%)
At close: Oct 22, 2026

Bacil Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
293685610863234
Market Cap Growth
-52.47%12.33%607.73%166.97%-4.36%83.65%
Enterprise Value
339669610832833
Last Close Price
20.4447.7342.4914.635.485.73

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
23.8444.04150.92---
PB Ratio
1.162.762.407.102.942.76
P/TBV Ratio
1.162.762.407.102.942.76
P/FCF Ratio
-96.27152.16---
P/OCF Ratio
-96.27152.16---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/FCF Ratio
-94.03152.28---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.22-0.010.080.020.03
Debt / FCF Ratio
--0.41---
Net Debt / Equity Ratio
0.18-0.02-0.110.05-0.18-0.22
Net Debt / EBITDA Ratio
-2.3310.67-0.301.121.76
Net Debt / FCF Ratio
--0.80-6.72-19.641.350.07
Quick Ratio
0.370.6817.200.377.876.49
Current Ratio
1.240.6817.210.468.196.69
Return on Equity (ROE)
3.04%6.19%3.03%-5.11%-8.77%-295.12%
Return on Assets (ROA)
-0.40%-0.58%-1.18%-9.62%-9.37%-3.70%
Return on Invested Capital (ROIC)
-0.67%-1.04%-2.09%-17.40%-19.41%-13.92%
Return on Capital Employed (ROCE)
-0.70%-1.00%-1.00%-15.60%-16.30%-13.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
4.19%2.27%0.66%-0.69%-3.16%-114.37%
FCF Yield
-1.04%0.66%-0.03%-4.57%-118.79%
Buyback Yield / Dilution
11.03%-121.94%-6.92%1.47%-1.71%-0.99%